Friday’s analyst upgrades and downgrades

National Bank generally turned more constructive on precious metals and uranium/lithium names, while trimming 2026 gold and silver price assumptions to US$5,000/oz and US$80/oz, respectively, and leaving long-term gold/silver estimates at US$3,200 and US$42. The firm raised multiple targets, including Cameco to $175, Denison to $6.50, Lithium Argentina to US$12, and Orezone to $3.75, while downgrading Newmont to sector perform with a lower US$130 target amid higher cost and M&A risk. It also flagged ongoing geopolitical and supply-chain risks, but sees buybacks and improving commodity fundamentals supporting select miners and lifecos.

Analysis

The key second-order read-through is that the commodity complex is bifurcating between “quality duration” and “operational beta.” In gold, higher input-cost pressure and geopolitical risk don’t lift all miners equally: low-cost, jurisdictionally clean names with visible buybacks should rerate first, while open-pit / frontier-geo producers face margin compression even if bullion stays firm. That argues for relative value long AEM/AGI/PAAS/IMG and short lower-quality cost-takers where execution risk can overwhelm commodity upside.

Uranium is the cleaner momentum trade, but the real edge is in the term market, not spot. Spot can remain headline-driven and mean-revert as trust buying ebbs, while contracting improvement supports the names with scale, liquidity and near-term production optionality. That keeps CCO and NXE as the highest-conviction ways to express the thesis, while smaller/high-cost ISR producers should lag as financing costs and restart capex stay punitive.

In lithium, the market is transitioning from “survival” to “price discovery,” which is much more bullish for brine-linked and FCF-positive producers than for optionality stories. If prices are staying above incentive levels through 2026, the best risk/reward is in assets that can self-fund growth and avoid another equity raise cycle; that should continue to compress the valuation gap between operating producers and developers. The contrarian risk is policy-driven supply response from China and Latin America landing faster than expected, which would hit the long-duration developers hardest.

For defensives, the lifeco setup is more about cleaner earnings delivery than macro beta. The market should reward reported EPS quality, excess-capital discipline, and international business normalization; that favors SLF and MFC over balance-sheet-heavy peers. In insurance, a modest beat is less important than confirming that private-credit marks and alternative returns are stabilizing, because that is what can drive multiple expansion over the next 2-3 quarters.

Key Decisions for Investors

• Long AEM / short NEM for 1-3 months: own the cleaner balance sheet, better jurisdiction mix, and buyback support while shorting the name most exposed to guidance risk and M&A overhang; target a 5-8% relative spread.
• Buy CCO and NXE on any 3-5% pullback over the next 2-4 weeks: use spot volatility as entry, but underwrite the trade to strengthening term contracting over the next 1-2 quarters; risk is a sharp reversal in utility buying.
• Pair long LAR vs short a high-cost lithium developer basket for 6-9 months: prefer self-funding brine exposure if prices stay elevated; hedge policy risk and Chinese supply restarts that would compress developer multiples fastest.
• Overweight SLF and MFC into Q1/Q2 earnings over GWO/IAG for the next 2 quarters: cleaner EPS and capital-return discipline should drive a multiple re-rate if reported/core earnings divergence narrows.
• For gold beta, favor ORE.TO as a special situation long only if comfortable with jurisdictional risk; otherwise use it as a smaller tactical position and pair against a weaker frontier miner to isolate rerating from the Casa Berardi mix shift.